McKesson Corporation (MCK:NYSE) closed at $976.57 on October 14, 2026, up 1.53% on the day. The stock trades 2.2% below its 52-week high of $999.00 and 34.9% above its 52-week low of $723.68. Over the past year, it gained 23.3%. McKesson Corporation is part of the Health Care sector (Other Pharmaceuticals).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +2.18% | +8.56% | +16.07% | +13.68% | +23.32% |
In 252 trading sessions since October 14, 2025, MCK closed higher on 132 days (52%). Its best day was February 5, 2026 (+16.52%) and its worst was May 6, 2026 (-7.16%). The stock moved 10% or more in a single session 1 time.
McKesson Corporation operates as a pharmaceutical distribution services and information technology company in the United States and internationally. It offers pharmaceuticals and medical supplies, and services for healthcare operations. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, equipment, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacies in Europe and supports independent pharmacy networks in North America; sells financial, operational, and clinical solutions to pharmacies; and provides consulting, outsourcing, and other services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and st...
Find more stocks like MCK with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.